CLINICAL-EXPERIENCE WITH LEUCOVORIN AND 5-FLUOROURACIL

被引：0
|
作者：
LAUFMAN, LR
BRENCKMAN, WD
STYDNICKI, KA
MORGAN, ED
COLLIER, M
KNICK, VB
DUCH, DS
MULLIN, R
FERONE, R
机构：
[1] COLUMBUS COMMUNITY CLIN ONCOL PROGRAM,COLUMBUS,OH
[2] DUKE UNIV,DURHAM,NC 27706
来源：
CANCER | 1989年 / 63卷 / 06期
关键词：
D O I：
10.1002/1097-0142(19890315)63:6+<1031::AID-CNCR2820631308>3.0.CO;2-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1031 / 1035
页数：5
相关论文
共 50 条
  • [31] Leucovorin, 5-fluorouracil, and gemcitabine: A phase I study
    Elizabeth Poplin
    John Roberts
    Marybeth Tombs
    Steven Grant
    Eric Rubin
    Investigational New Drugs, 1999, 17 : 57 - 61
  • [32] Is oral tegafur with leucovorin equivalent to intravenous 5-fluorouracil and leucovorin in colorectal cancer?
    Friberg, G.
    Schilsky, R. L.
    NATURE CLINICAL PRACTICE ONCOLOGY, 2006, 3 (05): : 240 - 241
  • [33] Is oral tegafur with leucovorin equivalent to intravenous 5-fluorouracil and leucovorin in colorectal cancer?
    Gregory Friberg
    Richard L Schilsky
    Nature Clinical Practice Oncology, 2006, 3 : 240 - 241
  • [34] LEUCOVORIN INCREASES THE TOXICITY OF 5-FLUOROURACIL - PHASE-I CLINICAL PHARMACOLOGICAL TRIALS
    BRUCKNER, HW
    STORCH, JA
    HOLLAND, JF
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 192 - 192
  • [35] Intergroup randomized phase III study of postoperative irinotecan, 5-fluorouracil, and leucovorin versus oxaliplatin, 5-fluorouracil, and leucovorin versus 5-fluorouracil and leucovorin for patients with stage II or III rectal cancer receiving either preoperative radiation and 5-fluorouracil or postoperative radiation and 5-fluorouracil: ECOG E3201-An updated survival analysis.
    Nimeiri, Halla Sayed
    Feng, Yang
    Catalano, Paul J.
    Meropol, Neal J.
    Giantonio, Bruce J.
    Sigurdson, Elin R.
    Martenson, James A.
    Whitehead, Robert P.
    Sinicrope, Frank A.
    Mayer, Robert J.
    O'Dwyer, Peter J.
    Benson, Al Bowen
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [36] Biochemical modulation of 5-fluorouracil with methotrexate in advanced colorectal cancer patients pretreated with adjuvant 5-fluorouracil and leucovorin
    Pronzato, P
    Vaira, F
    Vigani, A
    Losardo, P
    Bertelli, G
    ANTICANCER RESEARCH, 1995, 15 (6B) : 2679 - 2682
  • [37] Health-Related Quality of Life Impact of Bevacizumab When Combined with Irinotecan, 5-Fluorouracil, and Leucovorin or 5-Fluorouracil and Leucovorin for Metastatic Colorectal Cancer
    Kabbinavar, Fairooz F.
    Wallace, Joel F.
    Holmgren, Eric
    Yi, Jing
    Cella, David
    Yost, Kathleen J.
    Hurwitz, Herbert I.
    ONCOLOGIST, 2008, 13 (09): : 1021 - 1029
  • [38] Randomized trial comparing weekly bolus 5-fluorouracil plus leucovorin versus monthly 5-day 5-fluorouracil plus leucovorin in metastatic colorectal cancer
    Wang, WS
    Lin, JK
    Chiou, TJ
    Liu, JH
    Fan, FS
    Yen, CC
    Lin, TC
    Jiang, JK
    Yang, SH
    Chen, PM
    HEPATO-GASTROENTEROLOGY, 2000, 47 (36) : 1599 - 1603
  • [39] Trimetrexate as a biochemical modulator of 5-fluorouracil and leucovorin in colorectal cancer
    Punt, CJA
    SEMINARS IN ONCOLOGY, 2000, 27 (05) : 88 - 90
  • [40] Pulmonary Fibrosis Under Chemotherapy with Oxaliplatin, 5-fluorouracil, and Leucovorin
    Jung, Jin Yong
    Hur, Gyu Young
    Jung, Ki Hwan
    Jung, Hae Chul
    Lee, Sung Yong
    Choi, In Keun
    Lee, Sang Yeub
    Kim, Je Hyeong
    Seo, Jae Hong
    Shin, Chol
    Shim, Jae Jeong
    In, Kwang Ho
    Kang, Kyung Ho
    Yoo, Se Hwa
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2005, 59 (05) : 536 - 540
12345